Markets
Best Buy retail store, company logo on building exterior, Manhattan, New York City, New York, USA
(Plexi Images/Getty Images)

Best Buy posts strong Q2 but keeps guidance cautious as tariffs loom

Shoppers snapped up AI gadgets and Nintendo Switch 2s in the second quarter, but tariffs are keeping the retailer’s outlook in check.

8/28/25 12:55PM

Best Buy shares were down 4% Thursday afternoon after the electronics retailer delivered a solid Q2 but held its full-year guidance steady.

Adjusted diluted earnings per share came in at $1.28, beating the Street’s estimate of $1.21, while revenue hit $9.44 billion, above analysts calls for $9.23 billion. Same-store sales climbed 1.6%, versus an expected decline of 0.5%.

Looking ahead: Best Buy maintained its full-year outlook, projecting revenue of $41.1 billion to $41.9 billion and adjusted EPS of $6.15 to $6.30. While a bit above Wall Street’s $6.16 forecast, the guidance landed a bit flat given the buzz around gadgets and gaming demand and the general trend of companies raising guidance during this reporting period.

“We delivered better-than-expected results in the second quarter, and we feel increasingly confident about our plans for the back half of the year,” the company said in a statement. “Given the uncertainty of potential tariff impacts in the back half, both on consumers overall as well as our business, we feel it is prudent to maintain the annual guidance we provided last quarter.”

To mitigate tariff pressure, Best Buy has worked with suppliers to diversify production out of China, slashing its share of product costs from 55% down to a range of 30% to 35%.

Management said gaming and AI are proving to be big draws. For the Switch 2 launch in June, Best Buy doubled its in-store merchandising space and brought in Nintendo game trucks so shoppers could try the console out. Meanwhile, its computing lineup now includes 125 AI-powered laptops and desktops, with about 70% sold only at Best Buy.

Best Buy shares are down about 16% year to date.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.